ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $12,620,000 | +8369.8% | 181,131 | +2402.5% | 0.57% | +8014.3% |
Q2 2021 | $149,000 | +210.4% | 7,238 | -19.6% | 0.01% | +250.0% |
Q1 2021 | $48,000 | -94.0% | 9,000 | -71.5% | 0.00% | -96.2% |
Q2 2020 | $795,000 | +609.8% | 31,587 | +435.4% | 0.05% | +766.7% |
Q1 2020 | $112,000 | -37.8% | 5,900 | +73.5% | 0.01% | -45.5% |
Q4 2019 | $180,000 | -38.4% | 3,400 | -54.1% | 0.01% | -59.3% |
Q3 2019 | $292,000 | -20.0% | 7,400 | -16.9% | 0.03% | -20.6% |
Q2 2019 | $365,000 | +69.8% | 8,900 | +17.1% | 0.03% | +54.5% |
Q1 2019 | $215,000 | -1.8% | 7,601 | -57.5% | 0.02% | +4.8% |
Q4 2018 | $219,000 | +298.2% | 17,901 | -0.6% | 0.02% | +425.0% |
Q3 2018 | $55,000 | -20.3% | 18,000 | -14.3% | 0.00% | -20.0% |
Q2 2018 | $69,000 | +245.0% | 21,000 | +727.1% | 0.01% | +400.0% |
Q4 2017 | $20,000 | -70.1% | 2,539 | -71.5% | 0.00% | -50.0% |
Q3 2017 | $67,000 | +55.8% | 8,910 | -51.3% | 0.00% | 0.0% |
Q2 2017 | $43,000 | +43.3% | 18,300 | +7.6% | 0.00% | +100.0% |
Q1 2017 | $30,000 | +328.6% | 17,000 | +507.1% | 0.00% | – |
Q4 2016 | $7,000 | +133.3% | 2,800 | -3.4% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 2,900 | +163.6% | 0.00% | – |
Q2 2016 | $4,000 | – | 1,100 | +10.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 1,000 | -76.9% | 0.00% | -100.0% |
Q4 2015 | $22,000 | – | 4,338 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |